✦ LIBER ✦

Renoprotective effects of low-dose valsartan in type 2 diabetic patients with diabetic nephropathy

✍ Scribed by Katsunori Suzuki; Satoshi Souda; Tomoo Ikarashi; Susumu Kaneko; Osamu Nakagawa; Yoshifusa Aizawa

Book ID: 117370559
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 96 KB
Volume: 57
Category: Article
ISSN: 0168-8227
DOI: 10.1016/s0168-8227(02)00098-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A renoprotective effect of low dose losa

A renoprotective effect of low dose losartan in patients with type 2 diabetes

✍ Hideaki Sawaki; Jungo Terasaki; Atsushi Fujita; Seiko Nakagawa; Norio Kanatsuna; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 274 KB

Very high doses of valsartan provide ren

Very high doses of valsartan provide renoprotection independently of blood pressure in a type 2 diabetic nephropathy rat model

✍ NAOTO TOMINAGA; ANNIE ROBERT; YUKO IZUHARA; SHUICHI OHTOMO; TAKASHI DAN; KAZUO C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

Renoprotective effect of aliskiren monot

Renoprotective effect of aliskiren monotherapy and aliskiren−pentoxifylline combination in hypertensive-diabetic type 2 patients with diabetic nephropathy

✍ Hamed, Amin T.; Taha, Mohammed M.; Nasser, Luay M. 📂 Article 📅 2013 🏛 Egypts Presidential Specialized Council for Educat 🌐 English ⚖ 563 KB

Optimal dose of lisinopril for renoprote

Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial

✍ K. J. Schjoedt; A. S. Astrup; F. Persson; E. Frandsen; F. Boomsma; K. Rossing; L 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 92 KB

Renoprotective Effect of the Angiotensin

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

✍ Lewis, Edmund J.; Hunsicker, Lawrence G.; Clarke, William R.; Berl, Tomas; Pohl, 📂 Article 📅 2001 🏛 Massachusetts Medical Society 🌐 English ⚖ 193 KB

Renoprotective effects of the angiotensi

Renoprotective effects of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

✍ E.J Lewis; L.G Hunsicker; W.R Clarkeet al 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 38 KB